Kevin Laliberte
Geen lopende functies
Loopbaan van Kevin Laliberte
Eerdere bekende functies van Kevin Laliberte
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AXSOME THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2021 | - |
| DOVA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-03-2017 | - |
Opleiding van Kevin Laliberte
| University of Michigan | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AXSOME THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
- Beurs
- Insiders
- Kevin Laliberte
- Ervaring
